Mercedes Romero

Mercedes Romero

Auto-generated profile, based on publicly available information

Mercedes Romero

Unidad de Micología, Hospital de Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2023 in Medical Mycology Case Reports
Verified
Journal Article
Open access
FMFernando Antonio Messina
Fernando Antonio Messina
GSGabriela Santiso
Gabriela Santiso
MRMercedes Romero
Mercedes Romero
ABAlexandro Bonifaz
Alexandro Bonifaz
MFMarisa Fernandez
Marisa Fernandez
Emmanuel MarinEmmanuel Marin
Emmanuel Marin
A case of tinea corporis by Trichophyton indotineae observed in Argentina is presented. The patient had a history of having spent 18 months in Tulum, Mexico. She was suffering from tinea corporis in the anterior region of both thighs and the gluteal area. A mycological study was performed and T. mentagrophytes complex was isolated. The fungus was later identified as T. indotineae by DNA sequencing and treatment with SUBA-itraconazole was initiated with good clinical response.

31 August 2023 in Biomédica
Verified
Journal Article
Open access
PDF file
FMFernando Antonio Messina
Fernando Antonio Messina
ABAndrés Benchetrit
Andrés Benchetrit
ABAndrea Bocassi
Andrea Bocassi
MRMaría de Las Mercedes Romero
María de Las Mercedes Romero
SBSofía Bauer
Sofía Bauer
GSGabriela Santiso
Gabriela Santiso
Introduction. Fungal infections in patients with COVID-19 was one of the most debated topics during the pandemic.Objectives. To analyze the clinical characteristics and evolution of people living with HIV/AIDS and coinfection with cryptococcus and COVID-19 (group A) or without it (group B).Materials and methods. This is an analytical and retrospective study. We reviewed medical records of patients with meningeal cryptococcosis between April 2020 and May 2021.Results. We studied 65 people living with HIV/AIDS and with cryptococcosis infection diagnosed from April 2020 to May 2021. Fifteen patients with HIV/AIDS suffered from cryptococcosis and COVID-19, and out of these, 14 presented meningitis (group A), while 28 suffered from meningeal cryptococcosis, but did not have COVID-19 (group B).Conclusions. No statistically significant differences were observed between the two groups (A and B) considering: intracranial hypertension, presence of Cryptococcus antigens in cerebrospinal fluid, sensorium deterioration or mortality.The detection of Cryptococcus antigens in serum by lateral flow assay was highly effective to rapidly diagnose cryptococcosis in patients with HIV/AIDS who also developed COVID-19. Patients of both groups consulted for cryptoccocosis sometime after, in comparison with the pre-pandemic cases related to this infection.

1 October 2024 in Revista Iberoamericana de Micologia
Verified
Journal Article
Closed access
GSGabriela Santiso
Gabriela Santiso
FMFernando Messina
Fernando Messina
MPMatías Gastón Pérez
Matías Gastón Pérez
DMDaniela Masini
Daniela Masini
MRMercedes Romero
Mercedes Romero
AAALICIA IRENE ARECHAVALA
ALICIA IRENE ARECHAVALA